title: Electrophysiologic effects of intravenous aminophylline in heart transplant recipients with sinus node dysfunction.
abstract: BACKGROUND
  Sinus node dysfunction has been reported to occur in up to 50% of orthotopic heart transplant recipients, and oral theophylline has been used in an attempt to limit the morbidity associated with this abnormality. The purpose of this study was to evaluate the electrophysiologic effects of methylxanthines on sinus node function.
  
  
  METHODS
  Sinus node testing performed in 26 patients before and after the infusion of 6 mg/kg of aminophylline. Thirteen of these patients had abnormal sinus node function at baseline, and thirteen had normal sinus node function. Sinus node dysfunction was diagnosed by a rhythm other than sinus in five patients, a prolonged corrected sinus node recovery time in two patients, and the presence of a secondary pause in six patients.
  
  
  RESULTS
  In patients with abnormal sinus node function a significant decrease was observed in the sinus node recovery time (-14% +/- 5%) and corrected sinus node recovery time (-33% +/- 25%) in response to aminophylline; however, neither parameter was normalized. A decrease in the sinus cycle length (-6% +/- 8%) was not statistically significant. In patients with normal sinus node function, a significant decrease was seen in both the sinus node recovery time (-9% +/- 7%) and sinus cycle length (-9% +/- 4%). The corrected sinus node recovery time decreased by 4% +/- 28% in patients with normal conditions but was not significant. Overall, aminophylline resolved the underlying sinus node abnormality in only one of thirteen patients with abnormal sinus node function.
  
  
  CONCLUSIONS
  This study suggests that the use of theophylline in patients with marked sinus node dysfunction may not decrease their risks for subsequent bradycardic events.
authors.affiliation: Temple University School of Medicine, Philadelphia, Pa 19140, USA.
authors.forename: S A
authors.initials: SA
authors.lastname: Rothman
authors.forename: V
authors.initials: V
authors.lastname: Jeevanandam
authors.forename: C P
authors.initials: CP
authors.lastname: Seeber
authors.forename: I L
authors.initials: IL
authors.lastname: Piña
authors.forename: H H
authors.initials: HH
authors.lastname: Hsia
authors.forename: A A
authors.initials: AA
authors.lastname: Bove
authors.forename: J M
authors.initials: JM
authors.lastname: Miller
mesh_terms: D000328:Adult; D000628:Aminophylline / Q000008:administration & dosage* / Q000494:pharmacology; D001146:Arrhythmia, Sinus / Q000150:complications / Q000188:drug therapy*; D004594:Electrophysiology; D016027:Heart Transplantation; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D012849:Sinoatrial Node / Q000187:drug effects* / Q000503:physiopathology
chemical_list: D000628:Aminophylline